The company has interests in creating transfer technology in engineering and physical sciences. The company works with independent, government, premier services, and industry clients, which allows them to assemble teams to tackle various problems.
In response to the outbreak of the COVID-19 (coronavirus) disease, Southwest Research Institute has provided virtual screening software for research on the virus. The company has evaluated two million drug compounds with the goal of identifying high-probability drugs that could be effective against the coronavirus, and cause minimal side effects.
The company's partnership with Texas Biomedical Research Institute has furthered their research for drug development candidates. Their Rhodium software can scan 250,000 drug compounds a day through graphical processing and machine learning techniques. The company used a 3D model of the coronavirus to evaluate potential drugs from a library of compounds. The system predicts how the protein structures in infectious diseases will bind with compounds, and then interpret the results for data analysis.
Beth Ann Rafferty
April 13, 2016
Southwest Research Institute | Crunchbase
SwRI's virtual screening software Rhodium increases processing power for coronavirus research
February 19, 2020
Who We Are
June 17, 2016
Documentaries, videos and podcasts
Southwest Research Institute
Thomas Baker Slick Jr
San Antonio, Texas, United States
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.
- CoronavirusCDC Coronavirus: Coronaviruses are common throughout the world. They can infect people and animals. Five different coronaviruses can infect people and make them sick. They usually cause mild to moderate upper-respiratory illness.